The DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.
Impact of severe acute respiratory syndrome (SARS) on pulmonary function, functional capacity and quality of life in a cohort of survivors
Open accessAbstract
OBJECTIVE: To examine the impact of severe acute respiratory syndrome (SARS) on pulmonary function, exercise capacity, and health-related quality of life (HRQoL) among survivors. METHODS: 110 survivors with confirmed SARS were evaluated at the Prince of Wales Hospital, HK at the end of 3 and 6 months after symptom onset. The assessment included lung volumes (TLC, VC, RV, FRC), spirometry (FVC, FEV1), carbon monoxide transfer factor (TLCO adjusted for haemoglobin), inspiratory and expiratory respiratory muscle strength (Pimax and Pemax), 6 minute walk distance (6MWD), chest radiographs, and HRQoL by SF-36 questionnaire. RESULTS: There were 44 men and 66 women with a mean (SD) age of 35.6 (9.8) years and body mass index of 23.1 (4.8) kg/m2. Seventy (64%) were healthcare workers. At 6 months 33 subjects (30%) had abnormal chest radiographs; four (3.6%), eight (7.4%), and 17 (15.5%) patients had FVC, TLC, and TLCO below 80% of predicted values; and 15 (13.9%) and 24 (22.2%) had Pimax and Pemax values below 80 cm H2O, respectively. The 6MWD increased from a mean (SD) of 464 (83) m at 3 months to 502 (95) m (95% CI 22 to 54 m, p<0.001), but the results were lower than normal controls in the same age groups. There was impairment of HRQoL at 6 months. Patients who required ICU admission (n = 31) had significantly lower FVC, TLC, and TLCO than those who did not. CONCLUSION: The exercise capacity and health status of SARS survivors was considerably lower than that of a normal population at 6 months. Significant impairment in surface area for gas exchange was noted in 15.5% of survivors. The functional disability appears out of proportion to the degree of lung function impairment and may be related to additional factors such as muscle deconditioning and steroid myopathy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Standardization of Spirometry, 1994 Update. American Thoracic Society.
(1995) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.152.3.7663792 · Cited by 6,594
Identification of a novel coronavirus in patients with severe acute respiratory syndrome
Drosten, C., Günther, S., Preiser, W., van der Werf, S., Brodt, H.-R., Becker, S., Rabenau, H., Panning, M., Kolesnikova, L., Fouchier, R. A. M., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030747 · Cited by 4,574
McHorney, C. A., Ware, J. E., Rachel Lu, J. F., & Sherbourne, C. D. (1994) · Medical Care · doi:10.1097/00005650-199401000-00004 · Cited by 4,458
A Novel Coronavirus Associated with Severe Acute Respiratory Syndrome
Ksiazek, T. G., Erdman, D., Goldsmith, C. S., Zaki, S. R., Peret, T., Emery, S., Tong, S., Urbani, C., Comer, J. A., Lim, W., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030781 · Cited by 4,344
A Major Outbreak of Severe Acute Respiratory Syndrome in Hong Kong
Lee, N., Hui, D., Wu, A., Chan, P., Cameron, P., Joynt, G. M., Ahuja, A., Yung, M. Y., Leung, C. B., To, K. F., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030685 · Cited by 2,628
Self-citationLung Function Testing: Selection of Reference Values and Interpretative Strategies
(1991) · American Review of Respiratory Disease · doi:10.1164/ajrccm/144.5.1202 · Cited by 2,510
Peiris, J., Chu, C., Cheng, V., Chan, K., Hung, I., Poon, L., Law, K., Tang, B., Hon, T., Chan, C., et al. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13412-5 · Cited by 2,375
One-Year Outcomes in Survivors of the Acute Respiratory Distress Syndrome
Herridge, M. S., Cheung, A. M., Tansey, C. M., Matte-Martyn, A., Diaz-Granados, N., Al-Saidi, F., Cooper, A. B., Guest, C. B., Mazer, C. D., Mehta, S., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022450 · Cited by 2,334
Reference Equations for the Six-Minute Walk in Healthy Adults
ENRIGHT, P. L., & SHERRILL, D. L. (1998) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.158.5.9710086 · Cited by 2,204
Maximal respiratory pressures: normal values and relationship to age and sex.
Black, L. F., & Hyatt, R. E. (1969) · PubMed · doi:10.1164/arrd.1969.99.5.696 · Cited by 1,877
Cited by
Nalbandian, A., Sehgal, K., Gupta, A., Madhavan, M. V., McGroder, C., Stevens, J. S., Cook, J. R., Nordvig, A. S., Shalev, D., Sehrawat, T. S., et al. (2021) · Nature Medicine · doi:10.1038/s41591-021-01283-z · Cited by 4,862
More than 50 long-term effects of COVID-19: a systematic review and meta-analysis
Lopez-Leon, S., Wegman-Ostrosky, T., Perelman, C., Sepulveda, R., Rebolledo, P. A., Cuapio, A., & Villapol, S. (2021) · Scientific Reports · doi:10.1038/s41598-021-95565-8 · Cited by 2,757
Rogers, J. P., Chesney, E., Oliver, D., Pollak, T. A., McGuire, P., Fusar-Poli, P., Zandi, M. S., Lewis, G., & David, A. S. (2020) · The Lancet Psychiatry · doi:10.1016/s2215-0366(20)30203-0 · Cited by 2,407
Halpin, S. J., McIvor, C., Whyatt, G., Adams, A., Harvey, O., McLean, L., Walshaw, C., Kemp, S., Corrado, J., Singh, R., et al. (2021) · Journal of Medical Virology · doi:10.1002/jmv.26368 · Cited by 1,402
1-year outcomes in hospital survivors with COVID-19: a longitudinal cohort study.
Huang, L., Yao, Q., Gu, X., Wang, Q., Ren, L., Wang, Y., Hu, P., Guo, L., Liu, M., Xu, J., et al. (2021) · The Lancet · doi:10.1016/s0140-6736(21)01755-4 · Cited by 1,101
Pulmonary fibrosis and COVID-19: the potential role for antifibrotic therapy
George, P. M., Wells, A. U., & Jenkins, R. G. (2020) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(20)30225-3 · Cited by 1,085
Phetsouphanh, C., Darley, D. R., Wilson, D. B., Howe, A., Munier, C. M. L., Patel, S. K., Juno, J. A., Burrell, L. M., Kent, S. J., Dore, G. J., et al. (2022) · Nature Immunology · doi:10.1038/s41590-021-01113-x · Cited by 1,015
Zhao, Y.-M., Shang, Y.-M., Song, W.-B., Li, Q.-Q., Xie, H., Xu, Q.-F., Jia, J.-L., Li, L.-M., Mao, H.-L., Zhou, X.-M., et al. (2020) · EClinicalMedicine · doi:10.1016/j.eclinm.2020.100463 · Cited by 927
Mandal, S., Barnett, J., Brill, S. E., Brown, J. S., Denneny, E. K., Hare, S. S., Heightman, M., Hillman, T. E., Jacob, J., Jarvis, H. C., et al. (2021) · Thorax · doi:10.1136/thoraxjnl-2020-215818 · Cited by 864
“These data are compatible with studies reporting longerterm abnormalities in SARS survivors [6], and initial data emerging from smaller COVID-19 cohorts [1, 7].”
Abnormal pulmonary function in COVID-19 patients at time of hospital discharge
Mo, X., Jian, W., Su, Z., Chen, M., Peng, H., Peng, P., Lei, C., Chen, R., Zhong, N., & Li, S. (2020) · European Respiratory Journal · doi:10.1183/13993003.01217-2020 · Cited by 810
Halpin, D. M. G., Criner, G. J., Papi, A., Singh, D., Anzueto, A., Martinez, F. J., Agusti, A. A., & Vogelmeier, C. F. (2021) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202009-3533so · Cited by 760
Wu, X., Liu, X., Zhou, Y., Yu, H., Li, R., Zhan, Q., Ni, F., Fang, S., Lu, Y., Ding, X., et al. (2021) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(21)00174-0 · Cited by 696
Pathological sequelae of long-haul COVID
Mehandru, S., & Merad, M. (2022) · Nature Immunology · doi:10.1038/s41590-021-01104-y · Cited by 657
Moldofsky, H., & Patcai, J. (2011) · BMC Neurology · doi:10.1186/1471-2377-11-37 · Cited by 604
“In previous studies of 3 weeks post discharge Appears to be 100% prevalence insomnia (two cases were severe) [4] One year complaints of sleep disturbance averaging 47% prevalence [26] Asia "peak of outbreak" Sleep problems noted, no incidence given [50] 6 months No discussion sleep [51] Summary 2005 No discussion slee…”
BackgroundRaman, B., Cassar, M. P., Tunnicliffe, E. M., Filippini, N., Griffanti, L., Alfaro-Almagro, F., Okell, T., Sheerin, F., Xie, C., Mahmod, M., et al. (2021) · EClinicalMedicine · doi:10.1016/j.eclinm.2020.100683 · Cited by 601
Respiratory function in patients post-infection by COVID-19: a systematic review and meta-analysis
Torres-Castro, R., Vasconcello-Castillo, L., Alsina-Restoy, X., Solis-Navarro, L., Burgos, F., Puppo, H., & Vilaró, J. (2021) · Pulmonology · doi:10.1016/j.pulmoe.2020.10.013 · Cited by 540
Sun, P., Qie, S., Liu, Z., Ren, J., Li, K., & Xi, J. (2020) · Journal of Medical Virology · doi:10.1002/jmv.25735 · Cited by 523
The COVID-19 puzzle: deciphering pathophysiology and phenotypes of a new disease entity
Osuchowski, M. F., Winkler, M. S., Skirecki, T., Cajander, S., Shankar-Hari, M., Lachmann, G., Monneret, G., Venet, F., Bauer, M., Brunkhorst, F. M., et al. (2021) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(21)00218-6 · Cited by 520
NGAI, J. C., KO, F. W., NG, S. S., TO, K., TONG, M., & HUI, D. S. (2010) · Respirology · doi:10.1111/j.1440-1843.2010.01720.x · Cited by 510
Self-citationvan den Borst, B., Peters, J. B., Brink, M., Schoon, Y., Bleeker-Rovers, C. P., Schers, H., van Hees, H. W. H., van Helvoort, H., van den Boogaard, M., van der Hoeven, H., et al. (2021) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa1750 · Cited by 466
Myall, K. J., Mukherjee, B., Castanheira, A. M., Lam, J. L., Benedetti, G., Mak, S. M., Preston, R., Thillai, M., Dewar, A., Molyneaux, P. L., et al. (2021) · Annals of the American Thoracic Society · doi:10.1513/annalsats.202008-1002oc · Cited by 433
Cardiopulmonary recovery after COVID-19: an observational prospective multicentre trial
Sonnweber, T., Sahanic, S., Pizzini, A., Luger, A., Schwabl, C., Sonnweber, B., Kurz, K., Koppelstätter, S., Haschka, D., Petzer, V., et al. (2021) · European Respiratory Journal · doi:10.1183/13993003.03481-2020 · Cited by 432
COVID-19: from an acute to chronic disease? Potential long-term health consequences
Higgins, V., Sohaei, D., Diamandis, E. P., & Prassas, I. (2021) · Critical Reviews in Clinical Laboratory Sciences · doi:10.1080/10408363.2020.1860895 · Cited by 405
Respiratory follow-up of patients with COVID-19 pneumonia
George, P. M., Barratt, S. L., Condliffe, R., Desai, S. R., Devaraj, A., Forrest, I., Gibbons, M. A., Hart, N., Jenkins, R. G., McAuley, D. F., et al. (2020) · Thorax · doi:10.1136/thoraxjnl-2020-215314 · Cited by 390
Hui, D. S., Wong, K. T., Ko, F. W., Tam, L. S., Chan, D. P., Woo, J., & Sung, J. J. Y. (2005) · Chest · doi:10.1378/chest.128.4.2247 · Cited by 368
Self-citationComorbidities, multimorbidity and COVID-19
Russell, C. D., Lone, N. I., & Baillie, J. K. (2023) · Nature Medicine · doi:10.1038/s41591-022-02156-9 · Cited by 368
The role of imaging in 2019 novel coronavirus pneumonia (COVID-19)
Yang, W., Sirajuddin, A., Zhang, X., Liu, G., Teng, Z., Zhao, S., & Lu, M. (2020) · European Radiology · doi:10.1007/s00330-020-06827-4 · Cited by 346
One-Year Outcomes and Health Care Utilization in Survivors of Severe Acute Respiratory Syndrome
Tansey, C. M. (2007) · Archives of Internal Medicine · doi:10.1001/archinte.167.12.1312 · Cited by 313
Mechanisms of Severe Acute Respiratory Syndrome Coronavirus-Induced Acute Lung Injury
Gralinski, L. E., Bankhead, A., Jeng, S., Menachery, V. D., Proll, S., Belisle, S. E., Matzke, M., Webb-Robertson, B.-J. M., Luna, M. L., Shukla, A. K., et al. (2013) · mBio · doi:10.1128/mbio.00271-13 · Cited by 310
Townsend, L., Dowds, J., O’Brien, K., Sheill, G., Dyer, A. H., O’Kelly, B., Hynes, J. P., Mooney, A., Dunne, J., Ni Cheallaigh, C., et al. (2021) · Annals of the American Thoracic Society · doi:10.1513/annalsats.202009-1175oc · Cited by 283
Salamanna, F., Veronesi, F., Martini, L., Landini, M. P., & Fini, M. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.653516 · Cited by 265
Parotto, M., Gyöngyösi, M., Howe, K., Myatra, S. N., Ranzani, O., Shankar-Hari, M., & Herridge, M. S. (2023) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(23)00239-4 · Cited by 263
Pulmonary Function and Radiologic Features in Survivors of Critical COVID-19
González, J., Benítez, I. D., Carmona, P., Santisteve, S., Monge, A., Moncusí-Moix, A., Gort-Paniello, C., Pinilla, L., Carratalá, A., Zuil, M., et al. (2021) · Chest · doi:10.1016/j.chest.2021.02.062 · Cited by 259
Role of JAK/STAT in Interstitial Lung Diseases; Molecular and Cellular Mechanisms
Montero, P., Milara, J., Roger, I., & Cortijo, J. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22126211 · Cited by 254
Physical Medicine and Rehabilitation and Pulmonary Rehabilitation for COVID-19
Wang, T. J., Chau, B., Lui, M., Lam, G.-T., Lin, N., & Humbert, S. (2020) · American Journal of Physical Medicine & Rehabilitation · doi:10.1097/phm.0000000000001505 · Cited by 243
COVID-19 and pulmonary fibrosis: a potential role for lung epithelial cells and fibroblasts
John, A. E., Joseph, C., Jenkins, G., & Tatler, A. L. (2021) · Immunological Reviews · doi:10.1111/imr.12977 · Cited by 219
Residual clinical damage after COVID-19: a retrospective and prospective observational cohort study
De Lorenzo, R., Conte, C., Lanzani, C., Benedetti, F., Roveri, L., Mazza, M. G., Brioni, E., Giacalone, G., Canti, V., Sofia, V., et al. (2020) · PLoS ONE · doi:10.1371/journal.pone.0239570 · Cited by 179
“Persistent radiological lung abnormalities and breathing difficulties were reported in patients recovered from previous coronavirus diseases [3, 4].”
BackgroundPulmonary rehabilitation for patients with coronavirus disease 2019 (COVID‐19)
Yang, L., & Yang, T. (2020) · Chronic Diseases and Translational Medicine · doi:10.1016/j.cdtm.2020.05.002 · Cited by 153
One‐year follow‐up CT findings in COVID‐19 patients: A systematic review and meta‐analysis
Watanabe, A., So, M., Iwagami, M., Fukunaga, K., Takagi, H., Kabata, H., & Kuno, T. (2022) · Respirology · doi:10.1111/resp.14311 · Cited by 139
“A SARS-CoV-1 study showed that abnormal chest radiographs were present in 30% of survivors at the 6-month follow-up.(29) The high prevalence (62% [15/24]) of pulmonary fibrosis in another study was also noteworthy.”
BackgroundResultCOVID-19 as a Risk Factor for Alzheimer’s Disease
Golzari-Sorkheh, M., Weaver, D. F., & Reed, M. A. (2023) · Journal of Alzheimer's Disease · doi:10.3233/jad-220800 · Cited by 39
Metadata
- Authors
- Hui, D. S.
- Venue
- Thorax
- Publisher
- BMJ
- Published
- 2005-05-01
- Volume
- 60
- Issue
- 5
- Pages
- 401-409
- ISSN
- 0040-6376 (ISSN-L)
- OpenAlex
- W2154153313
- Cited by
- 531
- References
- 54
- FWCI
- 3.43
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.